LUCID DIAGNOSTICS INC LUCD
COM · Common Stock · CUSIP 54948X109
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- HeadquartersNew York, NY
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 44.7m as of 2023-11-09, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.17.
Trends to Q3 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 24 |
| Q4 2022 | 24 |
| Q1 2023 | 20 |
| Q2 2023 | 19 |
| Q3 2023 | 25 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 9 | 14 |
| Q1 2023 | 7 | 8 |
| Q2 2023 | 7 | 7 |
| Q3 2023 | 11 | 6 |
Biggest buyers
| Ayrton Capital LLC | New | +73.9k |
| JANE STREET GROUP, LLC | New | +17.3k |
| LPL Financial LLC | Added | +14.0k |
| WELLS FARGO & COMPANY/MN | Added | +9.0k |
| Byrne Asset Management LLC | New | +7.2k |
| VANGUARD GROUP INC | Added | +5.7k |
| UBS Group AG | New | +5.5k |
| Tower Research Capital LLC (TRC) | Added | +3.0k |
| BANK OF AMERICA CORP /DE/ | New | +174 |
| Qube Research & Technologies Ltd | New | +104 |
Biggest sellers
| Nantahala Capital Management, LLC | Reduced | -40.9k |
| CITADEL ADVISORS LLC | Reduced | -26.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -11.6k |
| LUMINUS MANAGEMENT LLC | Reduced | -3.3k |
| BlackRock Inc. | Reduced | -2.6k |
| ROYAL BANK OF CANADA | Sold out | -95 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
PAVmed Inc.
13D · may seek influence
-0.8 pts · filed 2026-02-09
Stated purposeThe Reporting Person is the parent company of the Issuer. As a result of its ability to vote 27.5% of the Common Stock (and an estimated 26.3% of all the capital stock of the Issuer), the Reporting Person has the power to significantly influence the election of directors and all other matters that would require the vote of the outstanding shares of capital stock of the Issuer. Subject to the restrictions on transfer described in Item 6, the Reporting Person or any of the Principals, respectively, may acquire additional securities of the Issuer and may sell all or a portion of the securities then held in the open market or in privately negotiated transactions, although none of the Reporting Person or the Principals has any present intention to acquire or sell any securities of the Issuer ex… Full filing |
27.5% |
Insider purchases and sales in Q3 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 0 | — | 1 | $57.7k | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 1 | $49.1k | $49.1k |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2023-09-26 | Lapidus Stanley Director | Sold plan | $43.1k29.7k shares |
| 2023-09-25 | Lapidus Stanley Director | Sold plan | $286200 shares |
| 2023-09-21 | Lapidus Stanley Director | Sold plan | $144100 shares |
| 2023-09-20 | Lapidus Stanley Director | Sold plan | $5.5k3.8k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2023
| Manager | Shares | Change |
|---|---|---|
| LUMINUS MANAGEMENT LLC 0.32% of their portfolio | 875.1k $1.0m | Reduced -3.3k |
| VANGUARD GROUP INC 0.00% of their portfolio | 325.6k $380.9k | Added +5.7k |
| Nantahala Capital Management, LLC 0.02% of their portfolio | 158.1k $185.0k | Reduced -40.9k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 135.0k $157.9k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 131.9k $154.3k | Reduced -11.6k |
| Ayrton Capital LLC 0.59% of their portfolio | 73.9k $86.5k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 36.4k $42.6k | Reduced -26.1k |
| Verition Fund Management LLC 0.00% of their portfolio | 36.2k $42.3k | Unchanged |
| Geneos Wealth Management Inc. 0.00% of their portfolio | 33.9k $39.6k | Unchanged |
| LPL Financial LLC 0.00% of their portfolio | 28.4k $33.2k | Added +14.0k |
| BlackRock Inc. 0.00% of their portfolio | 23.7k $27.8k | Reduced -2.6k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 17.3k $20.3k | New |
| STATE STREET CORP 0.00% of their portfolio | 10.5k $12.3k | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 9.1k $10.6k | Added +9.0k |
| Byrne Asset Management LLC 0.01% of their portfolio | 7.2k $8.0k | New |
| UBS Group AG 0.00% of their portfolio | 5.5k $6.5k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.0k $3.5k | Added +3.0k |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 2.0k $2.3k | Unchanged |
| CWM, LLC 0.00% of their portfolio | 1.9k $2.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 200 $234 | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 174 $204 | New |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 104 $122 | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 13 $15 | New |
| HANTZ FINANCIAL SERVICES, INC. 0.00% of their portfolio | 10 $0 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |